NRx Pharmaceuticals, Inc. NRXP
Regular-session close
After hours · Nov 19, 7:16 PM ET
- YTD
- -5.90%
- 1 year
- +19.72%
Discussion (134)
Okay bought this in the 10s and been watching for weeks. EUA is back logged. They have used EUA over 600 times during the pandemic. Now, couple things going on with NRXP aviptadil is 1. Remdesivir is currently being used as a treatment and has already been approved and has manufacturing all set up. Aviptadil has been used for expanded access (which means whichever hospitals they chose in their clinical trial will be the only sites that can administer the drug to them). This means it is still very limited access. 2. NRXP has submitted to the FDA twice now for EUA. It is over the 60 days and it sounds like the FDA requested more data. I was wondering about this since the they are basing the efficacy on less than 200 patients. If you look at remdesivir, their study published in NEJM had 1062 in their studies (however the drug was already readily available). My guess is, FDA asked for data on more subjects. It is also a possibility the FDA will request data comparing aviptadil vs. remdesivir vs. placebo. Or maybe not. NRDX has people who used to work for the FDA on their board. I am sure those individuals reviewed the data prior to submitting to the FDA because they want to avoid getting rejected twice. Either way, given this companies deals with other companies and process in place for large manufacturing, I think this company is still a good buy.
Tipically
$NRXP: That boom ? is coming soon, it’s just a matter of time. Hope to see a reversal here before close. See what happen..
NRXP- Take all that political shit somewhere else bro. Tired of mf like you using this board fit your bullshit.
$NRXP fuck this shit and fuck you all
$NRXP- This is being held down for accumulation. The price action makes no sense given the expectation for their new Covid drug. They also just sign an agreement this week with Mannkind.
